Drug intelligence / Profile preview

anticholinergic + antidepressant

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Transdermal, Intranasal
01

Overview

This refers to a combination of an anticholinergic agent and an antidepressant. Anticholinergics are drugs that block the action of acetylcholine in the central and peripheral nervous system, leading to effects such as reduced muscle spasms, decreased bodily secretions, and sometimes cognitive impairment. Antidepressants are medications used primarily to treat depressive disorders; some classes (notably tricyclic antidepressants) possess significant anticholinergic properties themselves. There is no single pharmaceutical product universally recognized as "anticholinergic + antidepressant," but certain tricyclic antidepressants (such as amitriptyline) inherently combine both actions due to their pharmacology[2][4][8]. In rare cases, combination products or regimens may be used off-label for specific indications where both effects are desired.

02

Targets

SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on anticholinergic + antidepressant.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anticholinergic + antidepressant.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call